Main competitors
Dividend Yield (N) Dividend Yield (N+1) P/E (N) Price to Book (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Capi.($)
3.1%3.17%17.38x6.4x4.29x10.55x11.91x 32TCr
0.6%0.66%33.25x19.84x12.09x24.89x25.38x 1,01300Cr
2.24%2.33%25.49x6.42x5.87x15.97x17.66x 57TCr
3.05%3.22%27.54x-818.86x6.71x13.71x14.09x 40TCr
1.85%1.95%22.74x5.26x4.73x13.45x14.09x 28TCr
3.04%3.13%20.72x6.19x5.35x13x14.18x 27TCr
2.99%3.16%21.96x16.37x5.91x10.33x13.54x 18TCr
4.01%3.85%12.52x5.47x4.69x9.6x11.27x 19TCr
2.67%2.73%-43.47x8.25x5.27x29.72x59.15x 15TCr
6.84%6.82%11.97x1.66x3.15x7.66x8.92x 15TCr
4.52%4.65%10.9x4.82x3x8.03x8.72x 11TCr
-.--%-.--%24.91x5x7.5x16.92x17.61x 11TCr
5.6%5.93%11.33x1.22x2.19x7.09x8.05x 11TCr
3.64%3.8%12.38x4.56x2.69x7.92x8.92x 10TCr
1.81%2.07%24.35x5.54x8.3x15.69x16.42x 7.75TCr
3.94%4.04%45.12x1.12x2.64x9.73x27.6x 4.99TCr
0.58%0.65%33.42x4.51x7.39x24.56x25.39x 4.59TCr
0.63%2.09%15.13x1.23x1.46x6.93x11.57x 4.01TCr
-.--%-.--%30.2x3.98x3.01x10.57x11.89x 3.91TCr
2.35%2.61%17.65x1.76x3.24x12.21x13.68x 4.01TCr
Average 2.67% 2.84% 18.77x -35.46x 4.97x 13.43x 17.00x 21.3TCr
Weighted average by Cap. 2.38% 2.48% 21.87x -67.66x 6.76x 16.03x 18.31x
Other Pharmaceuticals
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!